Leading companies in the medical swab market are Puritan Medical Products (Maine, USA), BD (New Jersey, USA), 3M (Minnesota, USA), Copan Diagnostics Inc. (Italy, Europe), FL MEDICAL srl (Italy, Europe ), DLS Medical (UK, Europe), Dynarex (New York, USA), Advacare Pharma (Maharashtra, India)

The global medical swab market size is projected to reach US$4.59 billion by 2028, growing at a CAGR of 6.9% over the forecast period. The increasing technological innovations in swab production will create lucrative opportunities for this market, notes Fortune Business Insights in a report titled: “Medical Swab Market, 2021-2028.”The market size was $2.67 billion in 2020 and $2.88 billion in 2021.

Get a PDF sample brochure:https://www.fortunebusinessinsights.com/enquiry/sample/medical-swabs-market-103318

Remarkable development:

April 2021:The Mount Sinai Health System instituted the Mount Sinai COVID-19 PCR Saliva Testing Program to provide rapid, noninvasive, and accurate testing to support safety for businesses and recreational activities in New York.

Effects of COVID-19:

Sales of medical swabs increased during the COVID-19 pandemic due to the increased need for rapid diagnostic tests. The rising frequency of coronavirus infections is putting pressure on hospitals and diagnostic centers to conduct tests using sterile medical materials. This increased the swab production rate. Puritan Medical Products, for example, said in March 2020 that it would increase swab manufacturing to 1 million per week to maintain supply balance.

report coverage:

This report presents the growth drivers, obstacles and dynamics of the Medical Swabs Market. It indicates which companies would lead the market with the largest revenues. It also answers how the companies will increase sales of the product amid the COVID-19 pandemic. It also presents the regions and segments that would dominate the market in the coming years.

Regional Insights:

Increasing knowledge of infectious diseases to…